New methods enable deep coverage of the blood and tissue proteome, expand capabilities for dynamic biomarker discovery to include metabolites, lipids, and proteins
A novel platform paves the way for genomics-based oncology testing, with a knowledgebase of actionable biomarkers and help for scientists developing in-house tests.
Thermo Fisher Scientific | Jan 8, 2024 | 1 min read
Natural killer (NK) cells target infected and oncogenic cells, but are difficult to work with in vitro. Discover novel approaches to producing genetically modified NK cells for cell therapy.